To date, lecanemab is the first traditional approval of a treatment for Alzheimer’s disease. Lecanemab holds promise for patients in early stages of the disease.
The family of Bruce Willis recently revealed that the actor has been diagnosed with frontotemporal dementia, or FTD. While you’ve likely heard of dementia and associate the health condition with...
You are intent on going somewhere for a meaningful purpose. But when you reach your destination, you can't recall why you needed to be there. Could this common occurrence be...
Doctors aren't quite sure what causes sundowner's syndrome, but they do know people with Alzheimer's disease are prone to develop it, especially in the mid to late-stages of the disease.
Jason Shepherd, Ph.D., assistant professor of Neurobiology and Anatomy at University of Utah Health, is one of 17 recipients of the inaugural Ben Barres Early Career Acceleration Award from the...
Researchers at the University of Utah Health are looking to the salience network of the brain to develop music-based treatments to help alleviate anxiety in patients with dementia. Their research...
Scientists and musicians are joining forces as part of the Sound Health Initiative, a partnership between the National Institutes of Health and the Kennedy Center, to study exactly how music...
An experimental Alzheimer’s drug is stirring excitement as the first to show promise in slowing the pace of dementia. King is local director for a larger clinical trial that is...
